Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Lung Cancer (Amsterdam, Netherlands)
|
August 25, 1999
Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998
B R Leigh, D R Gandara, J J Crowley, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy
B R Leigh, P A Burke, A M Hong, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma
R T O'Donnell, B R Leigh, S D Christensen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2000
Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy
R H Chou, R B Wilder, M Ji, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2000
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
S J DeNardo, P A Burke, B R Leigh, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2001
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
G A Wiseman, C A White, R B Sparks, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Lung Cancer (Amsterdam, Netherlands)
|
August 25, 1999
Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998
B R Leigh, D R Gandara, J J Crowley, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy
B R Leigh, P A Burke, A M Hong, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma
R T O'Donnell, B R Leigh, S D Christensen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2000
Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy
R H Chou, R B Wilder, M Ji, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2000
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
S J DeNardo, P A Burke, B R Leigh, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2001
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
G A Wiseman, C A White, R B Sparks, et al.
Page
of 2